Edward J. Fox

Neurology

1201 W 38th St
Austin, TX 78705

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Plasma Proteomic Networks Reveal Shared Biology with Brain Linked to Alzheimer's Disease Pathology.

Plasma Proteomic Networks Reveal Shared Biology with Brain Linked to Alzheimer's Disease Pathology.

Journal: medRxiv : the preprint server for health sciences

Published: June 12, 2026

Correction: Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics.

Correction: Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics.

Journal: Trials

Published: May 29, 2026

Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study.

Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study.

Journal: JAMA neurology

Published: February 16, 2026

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Journal: Frontiers in immunology

Published: December 19, 2025

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis.

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis.

Journal: Neurology and therapy

Published: December 16, 2025

CSF Proteomics and Machine Learning Reveal Distinct Stages Across the Alzheimer's Disease Continuum.

CSF Proteomics and Machine Learning Reveal Distinct Stages Across the Alzheimer's Disease Continuum.

Journal: medRxiv : the preprint server for health sciences

Published: November 26, 2025

Multi-scale integration of human brain vascular and CSF proteomes reveals biomarkers of cerebral amyloid angiopathy linked to Alzheimer's disease risk.

Multi-scale integration of human brain vascular and CSF proteomes reveals biomarkers of cerebral amyloid angiopathy linked to Alzheimer's disease risk.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Cerebrospinal fluid proteomics for predictive assessment of Alzheimer's Disease risk.

Cerebrospinal fluid proteomics for predictive assessment of Alzheimer's Disease risk.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

CSF proteogenomics implicates novel proteins and humoral immunity in Alzheimer's disease risk.

CSF proteogenomics implicates novel proteins and humoral immunity in Alzheimer's disease risk.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression.

Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression.

Journal: bioRxiv : the preprint server for biology

Published: July 15, 2025

Proteomic subtyping of Alzheimer's disease CSF links blood-brain barrier dysfunction to reduced levels of tau and synaptic biomarkers.

Proteomic subtyping of Alzheimer's disease CSF links blood-brain barrier dysfunction to reduced levels of tau and synaptic biomarkers.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 07, 2025

Proteomic Subtyping of Alzheimer's Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic Biomarkers.

Proteomic Subtyping of Alzheimer's Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic Biomarkers.

Journal: bioRxiv : the preprint server for biology

Published: March 31, 2025

Showing 1-12 of 131

Last Updated: 09/26/2026